University City, MO, United States of America

Jonathan E McDunn

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jonathan E McDunn

Introduction

Jonathan E McDunn is an accomplished inventor based in University City, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of targeted therapeutic delivery systems. With a total of two patents to his name, McDunn's work focuses on innovative methods for treating serious medical conditions.

Latest Patents

One of McDunn's latest patents is titled "Modular platform for targeted therapeutic delivery." This patent discloses pharmaceutical compounds and compositions that include a targeting moiety capable of binding to cell receptors with a high affinity. The targeting moiety is designed to selectively induce apoptosis in cancer cells, making it a promising approach for cancer treatment. The methods described in this patent also allow for the co-administration of radiation therapy and additional chemotherapeutic agents.

Another significant patent by McDunn is "Membrane-permeant peptide complexes for treatment of sepsis." This patent outlines methods and compositions for treating sepsis using cell membrane-permeant peptide conjugate compounds that exhibit target cell specificity. These innovations aim to improve treatment outcomes for patients suffering from this serious condition.

Career Highlights

Jonathan E McDunn is affiliated with Washington University, where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize treatment protocols in the pharmaceutical industry.

Collaborations

McDunn has collaborated with notable colleagues, including William G Hawkins and Robert H Mach. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jonathan E McDunn's innovative contributions to pharmaceutical sciences demonstrate his commitment to improving medical treatments. His patents reflect a deep understanding of targeted therapies and their potential to address critical health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…